Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: SANGAMO THERAPEUTICS INC(SGMOQ) the Revenue is 1.442 M (-77.6%), Miss estimate;the EBIT is -31.95 M (-7.82%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B77.60%
0.01B80.73%
-0.01B158.33%
EBITMiss expectations
-0.03B7.82%
-0.02B17.87%
-0.01B25.69%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf